2′-Amino-2′-deoxycytidine
2′-Amino-2′-deoxycytidine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[26889-42-9]
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/2-amino-2-deoxycytidine.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1[C@@H](O)[C@@H](N)[C@H](N2C(N=C(N)C=C2)=O)O1
Molecular Formula
C9H14N4O4
Molecular Weight
242.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal TRAILR4/TNFRSF10D/DcR2 Antibody (104918R) [Janelia Fluor 585]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Mouse Monoclonal TRAILR4/TNFRSF10D/DcR2 Antibody (104918R) [Janelia Fluor 585]
TTC13, NT (TTC13, Tetratricopeptide repeat protein 13) (MaxLight 405) discontinued